protein 880 words KG: SMPD1PROTEIN
Contents

Acid Sphingomyelinase (ASM) Protein

🔬 Protein Info
Gene SymbolSMPD1
AliasesAcid sphingomyelinase, ASM, Page for SMPD1 Gene
Chromosome11p15.4
Protein TypeEnzyme
Target ClassEnzyme
FunctionThe SMPD1 gene encodes acid sphingomyelinase (ASM), a lysosomal hydrolase enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide and phosphorylcholine.
Mechanism of ActionSmall molecule inhibitor or modulator of sphingomyelinase activity
Primary Expressionneurons, astrocytes, microglia, and oligodendrocytes, with particular importance in white matter tracts
DruggabilityMedium (0.47)
Clinical StageApproved
Molecular Weight75 kDa
PathwaysSphingolipid metabolism, Lysosomal degradation, Ceramide signaling
UniProt IDP17405
NCBI Gene ID6609
Ensembl IDENSG00000166311
OMIM257200
GeneCardsSMPD1
Human Protein AtlasSMPD1
Associated DiseasesAging, Als, Alzheimer, Alzheimer's disease
Known Drugs/CompoundsOlipudase alfa
InteractionsAGING, ALPHA-SYNUCLEIN, ALS, App, asah1, ASAH1
SciDEX TargetView Target Profile (7 clinical trials)
SciDEX HypothesesSenescent Cell ASM-Complement Cascade Intervention
Selective Acid Sphingomyelinase Modulation Therapy
SMPD1 (Acid Sphingomyelinase) Inhibition for Ceram (+2 more)
KG Connections532 knowledge graph edges
DatabasesGeneCardsHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

UniProtWikipedia

Related Hypotheses (7)

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78
Sphingomyelin Synthase Activators for Raft Remodeling
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.62
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.62
Sphingolipid Metabolism Reprogramming
Score: 0.62

Related Analyses (7)

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed

Related Experiments (12)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40

See Also (1)

Neurodegeneration
disease · KG edge: implicated_in

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.